Paid Clinical Trials in New Jersey

New Jersey has 1,726 paid clinical trials enrolling now across cities including New Brunswick, Middletown and Basking Ridge. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 4, 2026.

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

1,560 clinical trials

Get a weekly email when new trials open in New Brunswick, NJ.

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

for Colorectal Cancer

Sites in East Brunswick +10 more locations

Sponsor: Verastem, Inc.

Sex: All·Age: 18+

Code: NCT07659795·Phase 2·Recruiting·Listed Jun 2026

Apply to this trial

A Study of Real-World Characteristics, Treatment Patterns, and Clinical Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer

for Prostatic Neoplasms, Castration-Resistant

1 location in East Hanover

Sponsor: Novartis Pharmaceuticals

Sex: Male·Age: 18 - 115

Code: NCT07677254·Recruiting·Listed Jun 2026

Apply to this trial

A Study of Real-World Characteristics, Treatment Patterns, and Outcomes Among mCRPC Patients Previously Treated With an Androgen Receptor Pathway Inhibitor, Taxane-Based Chemotherapy, and Lutetium-177 Vipivotide Tetraxetan

for Prostatic Neoplasms, Castration-Resistant

1 location in East Hanover

Sponsor: Novartis Pharmaceuticals

Sex: Male·Age: 18 - 115

Code: NCT07677267·Recruiting·Listed Jun 2026

Apply to this trial

A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

for Malignant Neoplasm

Sites in New Brunswick +10 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 1 Month - 17

Code: NCT07630974·Phase 1, Phase 2·Recruiting·Listed Jun 2026

Apply to this trial

Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

for Pancreatic Cancer

Sites in East Brunswick +5 more locations

Sponsor: Revolution Medicines, Inc.

Sex: All·Age: 18+

Code: NCT07621718·Phase 3·Recruiting·Listed Jun 2026

Apply to this trial

A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1

for HIV-1-infection

Sites in Somers Point, Hillsborough +28 more locations

Sponsor: Gilead Sciences

Sex: All·Age: 18+

Code: NCT07645287·Phase 2·Recruiting·Listed Jun 2026

Apply to this trial

A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are Tolerated When Taken Alone and Together With Ezabenlimab

for Advanced Solid Cancer

Sites in Hackensack +3 more locations

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT07607678·Phase 1·Recruiting·Listed May 2026

Apply to this trial

A Study to Learn About Heart-Related Risks in Elderly Men With Advanced Prostate Cancer Treated With Enzalutamide or Darolutamide

for Prostate Cancer

1 location in Whippany

Sponsor: Bayer

Sex: Male·Age: 55+

Code: NCT07672119·Recruiting·Listed Jun 2026

Apply to this trial

Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration

for Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD

Drug: Ixo-vec

Sites in Teaneck +11 more locations

Sponsor: Adverum Biotechnologies, Inc.

Sex: All·Age: 50+

Code: NCT07630649·Phase 2·Recruiting·Listed Jun 2026

Apply to this trial

A Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients

for Gastroenteropancreatic Neuroendocrine Tumor

1 location in East Hanover

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 110

Code: NCT07635316·Recruiting·Listed Jun 2026

Apply to this trial

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of ABS-1230 in Pediatric and Young Adult Participants With KCNT1-related Epilepsy

for KCNT1-Related Epilepsy

1 location in Hackensack

Sponsor: Actio Biosciences, Inc.

Sex: All·Age: 1 Month - 21

Code: NCT07600736·Phase 2·Recruiting·Listed May 2026

Apply to this trial

Study of GS-2426 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in East Brunswick +3 more locations

Sponsor: Gilead Sciences

Sex: All·Age: 18+

Code: NCT07601243·Phase 1·Recruiting·Listed May 2026

Apply to this trial

Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications

for Negative Symptoms of Schizophrenia

Sites in Marlton +12 more locations

Sponsor: Minerva Neurosciences

Sex: All·Age: 18 - 55

Code: NCT07565428·Phase 3·Recruiting·Listed May 2026

Apply to this trial

A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation

for Non-small Cell Lung Cancer (NSCLC)

Sites in Edison +3 more locations

Sponsor: Astellas Pharma Global Development, Inc.

Sex: All·Age: 18+

Code: NCT07566052·Phase 3·Recruiting·Listed May 2026

Apply to this trial

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

for Focal Seizure

Sites in Hackensack +10 more locations

Sponsor: Rapport Therapeutics Inc.

Sex: All·Age: 18 - 75

Code: NCT07563881·Phase 3·Recruiting·Listed May 2026

Apply to this trial

A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies

for Hematologic Neoplasms

Sites in Piscataway +5 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT07572006·Phase 1·Recruiting·Listed May 2026

Apply to this trial

An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.

for Hypertension (HTN)

Drug: QCZ484

Sites in Berlin +18 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07543120·Phase 2·Recruiting·Listed Apr 2026

Apply to this trial

A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice

for Asthma

Sites in Sewell +55 more locations

Sponsor: Sanofi

Sex: All·Age: 6+

Code: NCT07556159·Recruiting·Listed Apr 2026

Apply to this trial

A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread

for Prostate Cancer

Sites in Hackensack +1 more location

Sponsor: Regeneron Pharmaceuticals

Sex: Male·Age: 18+

Code: NCT07543055·Phase 1·Recruiting·Listed Apr 2026

Apply to this trial

EXACT Study: A Blinded Study in Patients With Alport Syndrome to Evaluate Exaluren Efficacy and Safety

for Alport Syndrome, X-Linked

Sites in Hackensack +7 more locations

Sponsor: Eloxx Pharmaceuticals, Inc.

Sex: All·Age: 12+

Code: NCT07523581·Phase 2·Recruiting·Listed Apr 2026

Apply to this trial

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

for Colorectal Cancer

Drug: Bevacizumab

Sites in East Brunswick +3 more locations

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT07525206·Phase 3·Recruiting·Listed Apr 2026

Apply to this trial

A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant

for Renal Transplant Failure and Rejection

Sites in Livingston +6 more locations

Sponsor: Nefro Avillion Clinical Development, LLC

Sex: All·Age: 18 - 70

Code: NCT07508787·Phase 2·Recruiting·Listed Apr 2026

Apply to this trial

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN

for Berger Disease

Sites in Neptune City +3 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 2 - 18

Code: NCT07498335·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

Method Comparison of Intelligent Fingerprinting Drug Screening System

for Drug Abuse Illicit

1 location in Marlton

Sponsor: Intelligent Bio Solutions Inc.

Sex: All·Age: 18 - 65·Accepts healthy volunteers

Code: NCT07650136·Recruiting·Listed Jun 2026

Apply to this trial

A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder

for Muscle-invasive Bladder Cancer

Sites in Cherry Hill, Washington Township +10 more locations

Sponsor: Astellas Pharma Global Development, Inc.

Sex: All·Age: 18+

Code: NCT07475806·Phase 2·Recruiting·Listed Mar 2026

Apply to this trial

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

for Epidermal Growth Factor

Sites in East Brunswick +5 more locations

Sponsor: EpiBiologics

Sex: All·Age: 18+

Code: NCT07462377·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234

for Atopic Dermatitis (AD)

Sites in Fair Lawn +1 more location

Sponsor: Arcutis Biotherapeutics, Inc.

Sex: All·Age: 18 - 65·Accepts healthy volunteers

Code: NCT07453602·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

for Primary Immune Thrombocytopenia (ITP)

Drug: Ianalumab

Sites in Summit +10 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07421167·Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

for Bladder Cancer

Sites in Morristown +10 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT07419295·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Hackensack +2 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT07414836·Phase 1·Recruiting·Listed Feb 2026

Apply to this trial

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

for PIK3CA Mutations

Sites in East Brunswick +10 more locations

Sponsor: Cogent Biosciences, Inc.

Sex: All·Age: 18+

Code: NCT07383506·Phase 1·Recruiting·Listed Feb 2026

Apply to this trial

To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer

for Breast Cancer

Sites in East Brunswick +2 more locations

Sponsor: Hoffmann-La Roche

Sex: All·Age: 18+

Code: NCT07368998·Phase 2·Recruiting·Listed Jan 2026

Apply to this trial

A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)

for Primary Myelofibrosis (PMF)

Drug: Ruxolitinib

Sites in Berkeley Heights +5 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07357727·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

for Chronic Myelogenous Leukemia

Sites in New Brunswick +3 more locations

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 1 - 18

Code: NCT07354074·Phase 2·Recruiting·Listed Jan 2026

Apply to this trial

Online Evaluation of the Diagnostic Accuracy of BlinkLab's Digital Assessments for Autism

for Autism

1 location in Princeton

Sponsor: Blinklab Limited

Sex: All·Age: 2 - 11·Accepts healthy volunteers

Code: NCT07590973·Recruiting·Listed May 2026

Apply to this trial

A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors

for Locally Advanced or Metastatic Malignant Solid Tumors

Sites in Hackensack +3 more locations

Sponsor: Astellas Pharma Global Development, Inc.

Sex: All·Age: 18+

Code: NCT07287995·Phase 1, Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B

for Hemophilia

Sites in Hackensack +4 more locations

Sponsor: Sanofi

Sex: Male·Age: 1 - 11

Code: NCT07285460·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

A Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on Immune Biomarkers in Subjects With Psoriasis

for Psoriasis

1 location in Englewood

Sponsor: Sirt3 LLC

Sex: All·Age: 18+

Code: NCT07471048·Recruiting·Listed Mar 2026

Apply to this trial

A Real-world Study of Remibrutinib in Chronic Spontaneous Urticaria Patients

for Chronic Spontaneous Urticaria

Drug: Remibrutinib

1 location in East Hanover

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 100

Code: NCT07408219·Recruiting·Listed Feb 2026

Apply to this trial

A Prospective Multicenter Clinical Investigation Evaluating the Accuracy of the Trimline Design When Treated With SureSmile® Aligners.

for Malocclusion

Sites in Princeton Junction +3 more locations

Sponsor: Dentsply Sirona Implants and Consumables

Sex: All·Age: 18+

Code: NCT07290790·Recruiting·Listed Dec 2025

Apply to this trial